Abstract:ABSTRACT Introduction Oral phosphodiesterase-5 (PDE5) inhibitors and intracavernous injection of prostaglandin E1 (PGE1) are common therapies for erectile dysfunction (ED) following radical prostatectomy (RP). However, these treatments are not always effective, and the development of a novel and effective therapy for ED following RP is required. Recently, mesenchymal stem cell (MSC) transplantation was shown to induce nerve regeneration and improves erectile function in a rat model of bilateral cavernous nerve injury (BCNI), a routinely used animal model of RP. Thus, MSCs are expected to be a novel therapy for ED following RP. However, the known risks of stem cell therapy include induction of embolization and immunoreactions. To avert these problems, we explored the suitability of using filtrated stem cell lysate, which contains secreted factors but does not contain MSCs. Objective In this study, we investigated the effects of filtrated bone marrow-derived stem cells lysate (BSCL) on erectile function in a rat model of BCNI. We also investigated the neuroregenerative effects of BSCL using the major pelvic ganglia (MPG) of rats. Methods Bone marrow-derived stem cells were obtained from Wistar/ST rats. After culturing two or three passages, these cells were collected and diluted with phosphate buffered saline (PBS). We obtained BSCL by freeze fracturing and filtrating them. Two experiments were performed. Experiment I: Eight-week-old male Wistar/ST rats were divided into three groups: Sham+PBS (n=8), BCNI+PBS (n=8), and BCNI+BSCL (n=8). Rats in the Sham+PBS group underwent sham surgery as a control. Rats in the BCNI+PBS group underwent complete BCNI surgery. After both surgeries, PBS was injected into the corpus cavernosum. Rats in the BCNI+BSCL group also underwent BCNI surgery, but after surgery, BSCL was injected into the corpus cavernosum. After 4 weeks, erectile function was evaluated by measuring intracavernosal pressure (ICP)/mean arterial pressure (MAP) under stimulation of the cavernous nerve. Experiment II: the MPG were dissected from ten-week-old male Wistar/ST rats. The MPG were placed on Matrigel and incubated with PBS (n=4), BSCL (n=4), or vascular endothelial growth factor (VEGF) (n=4), which was used as a positive control. After 48 h, neurite outgrowth was measured using a z-stack microscope. Results ICP/MAP in the BCNI+PBS group was significantly lower than that in the Sham+PBS group (P<0.05), and ICP/MAP in the BCNI+BSCL group was significantly higher than that in the BCNI+PBS group (P<0.05). MPG treated with BSCL and VEGF had longer neurite outgrowth than those treated with PBS. Conclusions BSCL treatment improved erectile function in the BCNI rat model of RP. BSCL also exhibited neuroregenerative effects on rat MPG. This suggests that BSCL may regenerate a crushed cavernous nerve, which results in improved erectile function. Our findings suggest that BSCL may be a new approach for post-RP ED. Further study should be conducted to identify the active factors in BSCL. Disclosure Work supported by industry: no.

A potential treatment for erectile dysfunction: Effect of platelet-rich plasma administration on axon and collagen regeneration in cavernous nerve injury

The Effect of Platelet-Rich Plasma on Cavernous Nerve Regeneration in a Rat Model

Effect of Platelet Rich Plasma on the Regeneration of Cavernous Nerve:Experiment with Rats

Intracavernous injection of platelet-rich plasma reverses erectile dysfunction of chronic cavernous nerve degeneration through reduction of prostate hyperplasia evidence from an aging-induced erectile dysfunction rat model

Cavernous Nerve Injury Resulted Erectile Dysfunction and Regeneration

Effects of platelet-rich plasma glue placement at the prostatectomy site on erectile function restoration and cavernous nerve preservation in a nerve-sparing prostatectomy rat model

Dual effect of chitosan activated platelet rich plasma (cPRP) improved erectile function after cavernous nerve injury

Effect of Platelet-Derived Growth Factor-Bb on Gap Junction and Connexin43 in Rat Penile Corpus Cavernosum Smooth Muscle Cells.

Local Continuous Glial Cell Derived Neurotrophic Factor Release Using Osmotic Pump Promotes Parasympathetic Nerve Rehabilitation in an Animal Model of Cavernous Nerve Injury Induced Erectile Dysfunction

Low-Intensity Electrostimulation Enhances Neuroregeneration and Improves Erectile Function in a Rat Model of Cavernous Nerve Injury

(063) Effect of Phosphodiesterase Type 4 Inhibitor on Erectile Function Recovery and Nerve Regeneration After Cavernous Nerve Injury in Rats

The potential role of intracavernosal injection of platelet-rich plasma for treating patients with mild to moderate erectile dysfunction: A GRADE-Assessed systematic review and meta-analysis of randomized controlled trials

(028) Intracavernosal Injection of Platelet-Rich Plasma for the Treatment of Erectile Dysfunction: A Meta-Analysis of Randomized Placebo-Controlled Trials

Evaluating the efficacy and safety of platelet-rich plasma injection for erectile dysfunction: a systematic review and meta-analysis of randomized controlled trials

Intracavernous Injection of Platelet-Rich Plasma Therapy Enhances Erectile Function and Decreases the Mortality Rate in Streptozotocin-Induced Diabetic Rats

Erectile Dysfunction Treatment Using Stem Cell Delivery Patch in a Cavernous Nerve Injury Rat Model

Filtrated bone marrow-derived stem cell lysate may improve erectile function through nerve regeneration in a rat model of cavernous nerve injury

(117) Is Platelet-Rich Plasma Effective and Safe for Managing Erectile Dysfunction? A Meta-Analysis of Before-After Data from Clinical Studies

Efficacy and safety of platelet-rich plasma intracavernosal injection for patients with erectile dysfunction: A systematic review, meta-analysis, and meta-regression

Molecular pathogenesis and treatment of cavernous nerve injury-induced erectile dysfunction: A narrative review

Repeated platelet-rich plasma injections improve erectile dysfunction in a rat model of hyperhomocysteinemia